Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$9.20
-0.95-9.36%
At close: Dec 15, 4:00 PM EST
$9.24
0.040.43%
After Hours: 5:04 PM EST
Comments
Loading...
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Omeros (OMER) stock?
You can purchase shares of Omeros (NASDAQ:OMER) through any online brokerage.
Who are Omeros (OMER) competitors?
Other companies in Omeros’s space includes: Theravance Biopharma Inc (NASDAQ:TBPH), Zevra Therapeutics Inc (NASDAQ:ZVRA), GH Research PLC (NASDAQ:GHRS), SNDL Inc (NASDAQ:SNDL) and Bioage Labs Inc (NASDAQ:BIOA).
What is the forecast, or price target, for Omeros (OMER) stock?
Omeros has a consensus price target of $23.80.
What is the current price for Omeros (OMER)?
The stock price for Omeros (NASDAQ: OMER) is $9.24 last updated December 15, 2025 at 5:04 PM EST.
Does Omeros (OMER) pay a dividend?
There are no upcoming dividends for Omeros.
When is Omeros (NASDAQ:OMER) reporting earnings?
Omeros does not have any upcoming earnings scheduled.
Is Omeros (OMER) going to split?
There is no upcoming split for Omeros.
What sector and industry does Omeros (OMER) operate in?
Omeros is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
